Clearstead Advisors’s Guardant Health GH Stock Holding History

Clearstead Advisors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.4K	Buy	+96	New	+$10.4K	﹤0.01%	1883
2026 Q1	–	Sell	-1,141	Closed	-$117K	–	2487
2025 Q4	$117K	Buy	1,141 +1,093	+2,277%	+$97.8K	﹤0.01%	1086
2025 Q3	$3K	Sell	48 -76	-61%	-$4.13K	﹤0.01%	2336
2025 Q2	$6.45K	Buy	+124	New	+$5.54K	﹤0.01%	2036
2024 Q4	–	Sell	-75	Closed	-$1.72K	–	2132
2024 Q3	$1.72K	Hold	75	–	–	﹤0.01%	1854
2024 Q2	$2.17K	Sell	75 -122	-62%	-$2.84K	﹤0.01%	1807
2024 Q1	$4.73K	Hold	197	–	–	﹤0.01%	1185
2023 Q4	$5.33K	Buy	+197	New	+$5.17K	﹤0.01%	1157
2022 Q2	–	Sell	-51	Closed	-$3K	–	1339
2022 Q1	$3K	Hold	51	–	–	﹤0.01%	1145
2021 Q4	$5K	Hold	51	–	–	﹤0.01%	996
2021 Q3	$6K	Hold	51	–	–	﹤0.01%	1005
2021 Q2	$6K	Hold	51	–	–	﹤0.01%	856
2021 Q1	$8K	Hold	51	–	–	﹤0.01%	814
2020 Q4	$7K	Hold	51	–	–	﹤0.01%	765
2020 Q3	$6K	Hold	51	–	–	﹤0.01%	720
2020 Q2	$4K	Buy	+51	New	+$4.11K	﹤0.01%	684

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Clearstead Advisors's GH Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Guardant Health (GH) in Q2 2026: 96 shares worth $14.4K. The stake represents ﹤0.01% of the portfolio and ranks #1883 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in GH as recently as Q4 2025.

Clearstead Advisors first reported a position in GH in Q2 2020 and has held it in 16 quarters since. The position peaked at $117K in Q4 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Clearstead Advisors held 96 shares of Guardant Health worth $14.4K as of Q2 2026.
Guardant Health was a new Clearstead Advisors position in Q2 2026.
Guardant Health made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1883 holding.
Clearstead Advisors first reported a position in Guardant Health in Q2 2020 and has held it in 16 quarters since.
Clearstead Advisors's Guardant Health position peaked at $117K in Q4 2025.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.